Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 2024 Jefferies Healthcare Conference on June 5, 2024.

Chirag will present at 1:30 PM EST. A live webcast of the presentation will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

Investor Contact: Anthony DiMeo VP, Investor Relations & Media anthony.dimeo@amneal.com

Amneal Pharmaceuticals (NYSE:AMRX)
過去 株価チャート
から 10 2024 まで 11 2024 Amneal Pharmaceuticalsのチャートをもっと見るにはこちらをクリック
Amneal Pharmaceuticals (NYSE:AMRX)
過去 株価チャート
から 11 2023 まで 11 2024 Amneal Pharmaceuticalsのチャートをもっと見るにはこちらをクリック